- Molecular variability of FLT3/ITD mutants and their impact on the differentiation program of 32D cells: Implications for the biological properties of AML blasts2009 | Third Faculty of Medicine
- Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation2015 | Faculty of Medicine in Pilsen
- Monitoring of minimal residual disease in patients with core binding factor acute myeloid leukemia and the impact of C-KIT, FLT3, and JAK2 mutations on clinical outcome2009 | Second Faculty of Medicine
- Midostaurin, current overview and clinical experience of IHBT in 2021 - case reports2021 | First Faculty of Medicine
- Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia2012 | First Faculty of Medicine
- Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia2009 | Second Faculty of Medicine
- Prenatal origin of childhood AML occurs less frequently than in childhood ALL2006 | Third Faculty of Medicine, Second Faculty of Medicine
- Homeobox gene expression in acute myeloid leukemia is linked to typical underlying molecular aberrations2014 | Second Faculty of Medicine
- Pre-transplant Quantitative Determination of NPM1 Mutation Significantly Predicts Outcome of AIlogeneic Hematopoietic Stem Cell Transplantation in Patients with Normal Karyotype AML in Complete Remission2016 | First Faculty of Medicine, Faculty of Medicine in Pilsen
